Intelligent Pharma –based at Barcelona Science Park (PCB) and specializing in computational chemistry services for the pharmaceutical and biotechnological industries- recently opened a new office in Munich (Germany). It is the fifth international office that the company has set up in the last five years, after the opening of two European delegations at Heidelberg Technology Park (Germany) and the BioPark cluster in Welwyn Garden City (United Kingdom); another one in Cambridge, Massachusetts (United States); and the last one last February in Calgary, Alberta, (Canada), which focuses its activity in petrochemical research.
The new Munich office will enable the creation of a solid commercial platform for high value-added services in the pharmaceutical industry. The objective of the office will be to increase brand visibility and increase its market share in the Bavarian region.
“We chose Munich because it is an area with a very powerful industry and our market share is still low in that region. Currently we are the only service provider in computational chemistry with a presence in five countries and customers in twenty countries", says Dr. Ignasi Belda, founder and CEO of Intelligent Pharma.
Capital injection
In addition, Intelligent Pharma just recently received a public capital injection of 550,000 euros, from the Plan Avanza 2 program, promoted by the Ministry of Industry, Energy and Tourism, and from the Ayudas para Contratos Torres Quevedo call (from the Ministry of Economy and Competiveness.
With these resources, the company will continue to develop its virtual polypharmacology technology, Pythia, for the discovery of new action mechanisms of molecules with therapeutic potential.
“Pythia´s new version includes functionalities in high demand by the market, such as the inclusion of phenotypical data, the study of metabolic pathways, or interface improvements that allow to exclude or include new therapeutic targets in virtual studies”, explains Dr. Belda.
About Intelligent Pharma
Intelligent Pharma is a spin-off of the University of Barcelona founded in 2007 by a young entrepreneur, engineer Ignasi Belda, at the Bioincubator of the Barcelona Science Park. Currently, the company focuses on the development, commercialization and use of new technologies in computational chemistry and artificial intelligence for drug discovery. These services are aimed at public research institutions, as well as biotech, nutritional, cosmetic and most recently petrochemical companies.
In its nearly eight years of operation, Intelligent Pharma has received 15 awards for its innovation capacity and growth potential, among these, the EntrepreneurXXI award, offered by “la Caixa” and ENISA, and the BioEntrepreneurXXI award, granted by Barcelona Activa, Biocat and la Fundación "la Caixa”. The last two awards were Premio Príncep de Girona 2014 Empresa and the Recognition Award for Innovation granted by CECOT.
Barcelona Science Park
The Barcelona Science Park (PCB), created in 1997 by the University of Barcelona, promotes research, knowledge transfer and innovation through the intelligent management of spaces, services and relationships. Its aim is to stimulate the PCB Community composed of more than 2,000 researchers, entrepreneurs, businessmen and professionals, especially in the field of life-sciences- to help change ideas into innovations. Learn more about the PCB in www.pcb.ub.edu
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
The UPV leads the development of an intelligent system to reduce the u...
